IFN-gamma R1

IFN-gamma R1 Molekülinformation

Englischer Name	Interferon gamma receptor	Anzahl der inverkehr gebrachten Arzneimittel	11
Anzahl der klinischen Arzneimittel	2	Target-Alias
Höchste Forschungs- und Entwicklungsphase	Approved

Englischer Name	Interferon gamma receptor
Target-Alias
Anzahl der inverkehr gebrachten Arzneimittel	11
Anzahl der klinischen Arzneimittel	2
Höchste Forschungs- und Entwicklungsphase	Approved

IFN-gamma R1 Produktliste

Attribut
Protein (2)
Produktbibliothek
Online (2)
Spezies
Human (2)
Etikett
Fc Tag (1)His Tag (1)
Marker
Unconjugated (2)

Produktnummer	Spezies	Expressionssystem	Produktbeschreibung	Proteinstruktur	Reinheit	Eigenschaften	Vorbestellen/Bestellen
IF1-H5223	Human	HEK293	Human IFN-gamma R1 / IFNGR1 Protein, His Tag				In den Warenkorb legen
IF1-H5254	Human	HEK293	Human IFN-gamma R1 / IFNGR1 Protein, Fc Tag				In den Warenkorb legen

Gesamtmenge2

IFN-gamma R1 Molekülhintergrund

Interferon gamma receptor 1 (IFNGR1) is also known as CD antigen CD119, which belongs to the type II cytokine receptor family. IFNGR1 contains two fibronectin type-III domains and two Ig-like C2-type (immunoglobulin-like) domains. IFNGR1 / CD119 is receptor for interferon gamma. Two receptors bind one interferon gamma (IFNG) dimer.

Klinische Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Indikationen	Klinische Studie
rSIFN-co		Phase 3 Clinical	Sichuan Huiyang Life Science and Technology Corp	Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colonic Neoplasms; Colorectal Neoplasms; Coronavirus Disease 2019 (COVID-19); Hepatitis B, Chronic; Lung Neoplasms; Melanoma; Neuroendocrine Tumors; Prostatic Neoplasms	Details
Interferon gamma (aerosol, IPF/ COPD), Stony Brook University School of Medicine		Phase 2 Clinical	Nostrum, Nyu Langone Medical Center, Stony Brook University School Of Medicine	Pulmonary Disease, Chronic Obstructive	Details

Inverkehr gebrachte Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Frühestes Markenname	Frühestes Genehmigungsland	Früheste Indikation	Früheste Genehmigungsgesellschaft	Früheste Genehmigungsdatum	Indikationen	Klinische Studie
Interferon gamma biosimilar (Livzon Pharmaceutical Group)		Approved	Livzon Pharmaceutical Group Inc		Mainland China	Arthritis, Rheumatoid	Livzon Pharmaceutical Group Inc	1998-01-01	Arthritis, Rheumatoid	Details
Interferon gamma (Hayashibara)	OH-6000	Approved	Hayashibara	Ogamma	Japan	Skin Neoplasms	null	1997-08-05	Skin Neoplasms	Details
Recombinant interferon gamma (Shanghai Chemo Wanbang Biopharma)		Approved	Shanghai Kaimao Bio-Pharmaceutical Co Ltd	gamma, 伽玛	Mainland China	Arthritis, Rheumatoid; Liver Cirrhosis	Shanghai Kaimao Bio-Pharmaceutical Co Ltd	1998-01-01	Arthritis, Rheumatoid; Granulomatous Disease, Chronic; Liver Cirrhosis	Details
Interferon gamma-1a biosimilar (Shionogi)	S-6810	Approved	Shionogi & Co Ltd	Imunomax-γ	Japan	Mycosis Fungoides; Carcinoma, Renal Cell; Myocardial Infarction; Communicable Diseases	Shionogi & Co Ltd	1989-09-29	Carcinoma, Renal Cell; Communicable Diseases; Mycosis Fungoides; Myocardial Infarction	Details
Interferon gamma-1b	DasKloster-1001; DasKloster-1001-01; AMG-292	Approved	Genentech Inc	Imukin 1, Actimmune, Immukin	United States	Osteopetrosis; Granulomatous Disease, Chronic	Horizon Therapeutics Ireland Dac	1999-02-25	Adenocarcinoma, Mucinous; Aspergillosis; Candidemia; Colonic Neoplasms; Cystic Fibrosis; Eye Diseases, Hereditary; Friedreich Ataxia; Granulomatous Disease, Chronic; Hepatitis C, Chronic; HIV Infections; Idiopathic Pulmonary Fibrosis; Leukemia, Myeloid, Acute; Liver Cirrhosis; Lung Diseases; Macular Degeneration; Melanoma; Mycobacterium avium-intracellulare Infection; Myelodysplastic Syndromes; Osteopetrosis; Plaque psoriasis; Pneumonia; Pulmonary Aspergillosis; Pulmonary Fibrosis; Rectal Neoplasms; Retinal Degeneration; Retinal Diseases; Tuberculosis, Pulmonary; Uveitis; Uveitis, Anterior	Details
Interferon biosimilar (LG Life Sciences)		Approved	Lg Chemical Ltd			Leukemia	Lg Chemical Ltd	1989-01-01	Leukemia	Details
Interferon gamma-1a (Asubio Pharma)	SUN-4800	Approved	Asubio	Biogamma	Japan	Mycosis Fungoides	Asubio	1992-01-01	Mycosis Fungoides	Details
Interferon gamma biosimilar (Pharmaclon)		Approved	Pharmaclon	Ingaron	Russian Federation	Tuberculosis, Pulmonary; Influenza, Human; HIV Infections; Hepatitis B; Herpes Zoster; Warts; Hepatitis C; Chlamydia Infections; Neoplasms; Respiratory Distress Syndrome, Newborn; Prostatitis	Pharmaclon	2011-01-01	Chlamydia Infections; Condylomata Acuminata; Hepatitis B; Hepatitis C; Herpes Zoster; HIV Infections; Influenza, Human; Lentivirus Infections; Neoplasms; Papillomavirus Infections; Prostatitis; Respiratory Distress Syndrome, Newborn; RNA Virus Infections; Tuberculosis, Pulmonary; Warts	Details
Interferon Gamma (Materia Medica Holding)		Approved	Materia Medica Holding Research And Production Company	Anaferon					Bacterial Infections; Virus Diseases	Details
Interferon gamma biosimilar (Center for Genetic Engineering and Biotechnology)		Approved	Center For Genetic Engineering And Biotechnology						Idiopathic Pulmonary Fibrosis; Tuberculosis	Details
Interferon gamma biosimilar (Recpharma)		Approved	Recpharma	IMMUNEX					Granulomatous Disease, Chronic; Neoplasms; Osteoporosis; Virus Diseases	Details